Status:
COMPLETED
Yoga Practice for Breast or Ovarian Cancer Patients
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Collaborating Sponsors:
The City College of New York
Conditions:
Ovarian Cancer
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Previous research suggests that regular physical activity may make cancer survivors do better in the long run. Laboratory studies suggest that stress may be bad for cancer patients as well. The invest...
Eligibility Criteria
Inclusion
- Woman age 18 or older
- History of stage 0-III breast cancer or stage I-III ovarian cancer; all antitumor therapies, excluding hormonal therapy, have been completed at least 60 days prior to enrollment
- ECOG Performance Status 0-1 (within 90 days of enrollment)
- Sedentary: \<90 minutes/week of moderate-intensity (not exhausting, light perspiration, e.g. fast walking, tennis, easy bicycling, easy swimming, popular and folk dancing) physical activity during the preceding 2 months, and \<30 minutes/month of any high-intensity activity (heart beats rapidly, sweating, e.g. running, aerobics classes, cross country skiing, vigorous swimming, vigorous bicycling) in the past 2 months
Exclusion
- Evidence of active malignant disease
- Currently has breast implant (which limits the performance of many yoga poses)
- Significant cardiopulmonary disease, severe arthritis, glaucoma or any other medical conditions that make yoga practice unsafe as determined by a study investigator.
- Patient requires regular use of beta blockers or calcium channel blockers.
- Use of any medication that would interfere with the study's initial blood tests, including insulin or insulin secretagogues, corticosteroids, daily use of NSAIDs (except aspirin at no more than 81 mg/day) within 7 days of the initial study blood test.
- Unlikely to be compliant with the study intervention
Key Trial Info
Start Date :
November 24 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 11 2019
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT02305498
Start Date
November 24 2014
End Date
March 11 2019
Last Update
March 14 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065